001     308658
005     20260126120550.0
024 7 _ |a 10.1007/s10654-025-01350-6
|2 doi
024 7 _ |a pmid:41579289
|2 pmid
024 7 _ |a 0393-2990
|2 ISSN
024 7 _ |a 1573-7284
|2 ISSN
037 _ _ |a DKFZ-2026-00191
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Zhu, Chunsu
|0 P:(DE-He78)368f3ed21e01008fd56a1c7d3670c994
|b 0
|e First author
|u dkfz
245 _ _ |a Lifestyle factors and all-cause mortality in long-term cancer survivors: a population-based prospective cohort study.
260 _ _ |a [Cham]
|c 2026
|b Springer Nature Switzerland AG
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1769422585_3983769
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:C071#LA:C071# / epub
520 _ _ |a The association between healthy lifestyles and mortality in cancer survivors remains inconclusive with few evidence among long-term cancer survivors (LTCS, survived ≥ 5 years post-diagnosis). Our study aims to investigate the association between individual and combined healthy lifestyle factors and mortality in LTCS. We included 6,057 LTCS of breast, colorectal or prostate cancer from a multiple regions study in Germany. A healthy lifestyle score (HLS) comprising alcohol consumption, body mass index (BMI), physical activity and smoking was created and was classified into tertiles with higher tertile indicating healthier lifestyle. We used Cox proportional hazards regression to examine the associations of individual lifestyle factors and HLS with all-cause mortality among LTCS. A total of 2,015 death events occurred over a maximum follow-up period of 12.3 years. Compared with the lowest tertile, participants in the middle and highest tertile experienced a 27% and 32% lower mortality (middle [hazard ratio (HR), 0.73; 95% CI 0.65-0.83]; highest [HR, 0.68, 95% CI 0.61-0.76]). A significant dose-response relationship was observed (p- trend < 0.001). These associations were consistent across different demographic and clinical characteristics. In addition, full adherence to lifestyle recommendations for smoking (HR, 0.51, 95% CI 0.44-0.59), physical activity (HR, 0.78, 95% CI 0.70-0.86) and BMI (HR, 0.87, 95% CI 0.77-0.99) were significantly related to a lower mortality, after full adjustment. Adherence to an overall healthy lifestyle was associated with significantly lower all-cause mortality in LTCS, emphasizing the importance of maintaining and promoting a healthier lifestyle among LTCS.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a All-cause mortality
|2 Other
650 _ 7 |a Cancer survivors
|2 Other
650 _ 7 |a Life style
|2 Other
650 _ 7 |a Prospective study
|2 Other
700 1 _ |a Thong, Melissa
|0 P:(DE-He78)24fe6057396bec79d2638615b12eb989
|b 1
|u dkfz
700 1 _ |a Doege, Daniela
|0 P:(DE-He78)55389e9f54d8411e6e6eddcec489bb1b
|b 2
|u dkfz
700 1 _ |a Koch-Gallenkamp, Lena
|0 P:(DE-He78)13aa5fe9d9961c9fd67193befb0dcf88
|b 3
|u dkfz
700 1 _ |a Bertram, Heike
|b 4
700 1 _ |a Eberle, Andrea
|b 5
700 1 _ |a Holleczek, Bernd
|b 6
700 1 _ |a Nennecke, Alice
|b 7
700 1 _ |a Waldmann, Annika
|b 8
700 1 _ |a Zeißig, Sylke Ruth
|b 9
700 1 _ |a Pritzkuleit, Ron
|b 10
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 11
|u dkfz
700 1 _ |a Arndt, Volker
|0 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
|b 12
|e Last author
|u dkfz
773 _ _ |a 10.1007/s10654-025-01350-6
|0 PERI:(DE-600)2004992-4
|p nn
|t European journal of epidemiology
|v nn
|y 2026
|x 0393-2990
909 C O |o oai:inrepo02.dkfz.de:308658
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)368f3ed21e01008fd56a1c7d3670c994
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)24fe6057396bec79d2638615b12eb989
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)55389e9f54d8411e6e6eddcec489bb1b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)13aa5fe9d9961c9fd67193befb0dcf88
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2026
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
|d 2025-01-01
|w ger
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2025-01-01
|w ger
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2025-01-01
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J EPIDEMIOL : 2022
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-01
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-01
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b EUR J EPIDEMIOL : 2022
|d 2025-01-01
920 2 _ |0 I:(DE-He78)C071-20160331
|k C071
|l Cancer Survivorship
|x 0
920 1 _ |0 I:(DE-He78)C071-20160331
|k C071
|l Cancer Survivorship
|x 0
920 1 _ |0 I:(DE-He78)M320-20160331
|k M320
|l Koordinierungsstelle der Cancer Prevention GS
|x 1
920 0 _ |0 I:(DE-He78)C071-20160331
|k C071
|l Cancer Survivorship
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C071-20160331
980 _ _ |a I:(DE-He78)M320-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21